Use and misuse of antipsychotic drugs in patients with dementia in Alzheimer special care units

International Clinical Psychopharmacology

Volumn 24, Issue 2, 2009, Pages 97-104

  Nobili, Alessandro ^a,b   Pasina, Luca ^a   Trevisan, Silvia ^b   Riva, Emma ^b   Lucca, Ugo ^b   Tettamanti, Mauro ^b   Matucci, Marina ^c   Tarantola, Massimo ^c  

^a Drug Information Services for the Elderly   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Direzione Generate Famiglia e Solidarieta Sociale ^*  (Italy)

Author keywords

Antipsychotic drugs; Behavioural disturbances; Dementia; Special care units

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CARDIAC AGENT; CITALOPRAM; DIAZEPAM; DIURETIC AGENT; LORAZEPAM; NEUROLEPTIC AGENT; OXAZEPAM; PROMAZINE; RISPERIDONE; SERTRALINE; TRAZODONE; TRIAZOLAM;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEMENTIA; DEMOGRAPHY; DISABILITY; DRUG MISUSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; MALE; MENTAL DISEASE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COGNITION; COMORBIDITY; DEMENTIA; DRUG UTILIZATION; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROMAZINE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RESIDENTIAL FACILITIES; RISPERIDONE;

EID: 63849164173     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328323aaf0     Document Type: Article

References (43)

1. Alanen HM, Finne-Soveri H, Nora A, Leinonen E (2006). Use of antipsychotic medications among elderly residents in long-term institutional care: a three- year follow-up. Int J Geriatr Psychiatry 21:288-295.
2. Alexopoulos GS, Streim JE, Carpenter D (2004). Expert consensus guidelines for antipsychotic agents in older patients. J Clin Psychiatry 65 (Suppl 2):5-99.
3. Barton C, Yaffe C (2006). Reducing neuroleptic use in long-trm care setting. The Lancet Neurology 5:469-470.
4. Bellelli G, Frisoni GB, Bianchetti A, Boffelli S, Guerrini GB, Scotuzzi AM, et al. (1998). Special care units for demented patients: a multicentre study. The Geromtologist 38:456-462.
5. Berg L, Buckwalter KC, Chafetz PK, Gwyther LP, Holmes D, Koepke KM, et al. (1991). Special care units for persons with dementia. J Am Geriatr Soc 39:1229-1236.
6. Briesacher BA, Limcangco MR, Simona-Wastila L, Doshi JA, Levens SR, Shea DG, Stuart B (2005). The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 165:1280-1285.
7. Bronskill SE, Anderson GM, Sykora K, Wodchis WP, Gill S, Shulman Kl, Rochon PA (2004). Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J Am Geriatr Soc 52: 749-755.
8. Burton LC, Rovner BW, German PS, Brandt U, Rebecca DC (1995). Neuroleptic use and behavioural disturbance in nursing homes: a 1-year study. Int Psychogeriatr 7:535-545.
9. Carson S, McDonagh MS, Peterson K (2006). A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioural symptoms of dementia. J Am Geriatr Soc 54: 354-361.
10. Cummings JL (1997). Neuropsychiatric inventory: assessing psychopathology in patients with dementia. Neurology 48 (Suppl 6): S10-S16.
11. Curran S, Turner D, Musa S, Wattis J (2005). Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic group. Int J Geriatr Psychiatry 20:842-847.
12. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003). Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716-2724.
13. Folstein MF, Folstein SE, Mc Hugh PR (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
14. Fossey J, Ballard C, Juszczak E, James I, Alder R, Jacoby R, Howard R (2006). Effect of enhanced psychological care on antipsychotic use in nursing home residents with dementia: cluster randomised trial. BMJ 332:756-761.
15. Furniss L, Craig SKL, Burns A (1998). Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433-439.
16. Gobert M, D'hoore W (2005). Prevalence of psychotropic drug use in nursing homes for aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatry 20:712-721.
17. Gormely N, Howard R (1999). Should neuroleptics be used in the management of nursing home residents with dementia? Int J Geriatr Psychiatry 14: 509-511.
18. Grossberg GT, Desai AK (2003). Management of Alzheimer's disease. J Gerontol 58A:331-353.
19. Gurvich T, Cunningham JA (2000). Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 61:1437-1446.
20. Hermann N (2001). Recommendation for the management of behavioural
21. and psychological symptoms of dementia. Can J Neurol Sci 28 (Suppl 1): S96-S107.
22. Hughes CM, Lapane KL, Mor V (2000a). Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care 38: 1164-1173.
23. Hughes CM, Lapane KL, Mor V, Ikegami N, Jonsson P, Ljunggren G, Sgadari A (2000b). The impact of legislation on psychotropic drug use in using homes: a cross national perspective. J Am Geriatr Soc 48:931 -937.
24. Jencks SF, Clauser SB (1991). Managing behavior problems in nursing homes. JAMA 265:502-503.
25. Klein DA, Steinberg M, Galik E, Steele C, Sheppard JM, Warren A, et al. (1999). Wandering behaviour in community-resident persons with dementia. Int J Geriatr Psychiatry 14:272-279.
26. Lakey SL, Gray SL, Sales AEB, Sullivan J, Hedrick SC (2006). Psychotropic use in community residential care facilities: a prospective cohort study. Am J Geriatr Pharmacotherap 4:227-235.
27. Lasser RA, Sunderland T (1998). Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 46:202-207.
28. Lawrence RM, Scott K, Duggal A, Darwin C, Brooks E, Christodoulou G (2000). Medico-legal implications of drug treatment in dementia: prescribing out of licence. Psychiatric Bull 26:230-232.
29. Lee PE, Gill SS, Freedman M, Bronskill SE, Hiilmer MP, Rochon PA (2004). A typical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 329:75-79.
30. Lindesay J, Matthews R, Jagger C (2003). Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry 18:511 -519.
31. Liperoti R, Mor V, Lapane KL, Pedone C, Gambasi G, Bemabei R (2003). The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 64:1106-1112.
32. Macdonald AJD. Carpenter Gl, Box O, Roberts A, Sahu S (2002). Dementia and use of psychotropic medication in non-elderly mentally infirm nursing homes in South East England. Age Ageing 31:58-64.
33. Motsinger CD, Perron GA, Lacy TJ (2003). Use of atypical antipsychotic drugs in patients with dementia. Am Fam Physician 67:2335-2340.
34. Nobili A, Piana I, Balossi L, Pasina L, Matucci M, Tarantola M, et al. (2008). Alzheimer Special Care Units compared with traditional nursing home for dementia care. Are there differences at admission and in clinical outcomes? Alzheimer Dis Assoc Disord 22:352-361.
35. Oborne CA, Hooper R, Chi Li K, Swift CG, Jackson HD (2002). An indicator of appropriate neuroleptic prescribing in nursing homes. Age and Ageing 31:435-439.
36. Ott BR, Lapane KL, Gambassi G (2000). Gender differences in the treatment of behaviour problems in Alzheimer's disease. Neurology 54:427-432.
37. Parmalee PA, Thuras PD, Katz IR, Lawton MP (1995). Validation of cumulative ilness rating scale in a geriatric residential population. J Am Geritr Soc 13:130-137.
38. Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer Disease. N Engl Med 355:1525-1538.
39. Shah S, Vanclay F, Cooper B (1989). Improving the sensitivity of the Barthel index for stroke rehabilitation. J Clin Epidemiol 42:703-709.
40. Shorr Rl, Fought RL, Ray WA (1994). Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 Regulation. JAMA 271:358-362.
41. Sink KM, Holden KF, Yaffe K (2005). Pharmacological treatment of neuro- psychiatric symptoms of dementia. A review of evidence. JAMA 293: 596-608.
42. Snowdon J, Day S, Baker W (2005). Why and how antipsychotic drugs are used in 40 Sidney nursing homes. Int J Geriatr Psychiatry 20:1146-1152.
43. Spore D, Mor V, Hiris J, Larrat EP, Hawes C (1995). Psychotropic use among older residents of board and care facilities. J Am Geriatr Soc 43:1403-1409.